Citadel Advisors »

Werewolf Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Werewolf Therapeutics (HOWL) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Werewolf Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Werewolf Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Werewolf Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $83k 13k 6.48
2023-12-31 $98k 25k 3.86
2022-12-31 $26k 13k 2.05
2022-03-31 $89k 20k 4.43

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Werewolf Therapeutics

RA Capital Management
MPM Asset Management
Partner Fund Management
Adage Capital Partners GP
MPM Oncology Impact Management
Bank of America Corporation
Henderson Group
Rubric Capital Management
Vanguard Group
Monashee Investment Management
Eagle Health Investments
Sphera Funds Management
Verition Fund Management
Millennium Management
Geode Capital Management

View all funds holding Werewolf Therapeutics